Singapore markets closed

Elanco Animal Health Inc (5EA.MU)

Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
14.86+0.20 (+1.36%)
As of 08:05AM CET. Market open.
Full screen
Previous close14.66
Open14.86
Bid14.92 x N/A
Ask15.06 x N/A
Day's range14.86 - 14.86
52-week range7.58 - 15.16
Volume20
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date07 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GuruFocus.com

    Director William Doyle Acquires 15,000 Shares of Elanco Animal Health Inc (ELAN)

    Elanco Animal Health Inc (NYSE:ELAN), a company specializing in the development, manufacturing, and marketing of products for animal health and production, has reported an insider purchase filed with the SEC.

  • PR Newswire

    Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary

    Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O'Neill as the company's Executive Vice President, General Counsel and Corporate Secretary. O'Neill will be responsible for the global strategy and operations of the Company's legal team, ethics & compliance organization and ESG efforts.

  • Reuters

    UPDATE 1-Ancora seeks four board seats at Elanco amid push for changes

    Investment firm Ancora Holdings said it is pushing for four board seats at Elanco Animal Health and wants to replace the chief executive at the company that makes medicines and vaccinations for pets and livestock. Ancora nominated the director candidates, including one of the firm's executives, to Elanco's 12-person board and wants to oust CEO Jeffrey Simmons over what the activist investor calls poor performance. Elanco, which was spun out of pharmaceutical company Eli Lilly, is one of the world's leading developers and makers of animal health products and has a market value of $7.8 billion.